Hoover Daily Report
Analysis and Commentary
Analysis and Commentary

The Angel Is in the Details

by Henry I. Millervia TCS Daily
Wednesday, April 25, 2007

Twenty years ago, then-FDA Commissioner Frank Young and I began a Wall Street Journal op-ed thus: "Defining the terms 'biotechnology' and 'genetic engineering' isn't an easy task, since the terms don't represent natural groupings of processes or products...

In the News
In the News

Raise a glass for Yeltsin -- it's what he'd do

with George P. Shultzvia Seattle Post-Intelligencer
Wednesday, April 25, 2007

Boris Yeltsin did not appear for a scheduled session with Russian media at the conclusion of the 1993 Clinton-Yeltsin summit in Vancouver, B.C. Word came, amid knowing chuckles, that Russia's president was "indisposed" and under the weather...

In the News

Politics trumps pop culture

with Larry Diamondvia Stanford Daily
Wednesday, April 25, 2007

If naming a U.S. senator is no sweat, but you draw a blank on last season’s winner of American Idol, you are not alone...

In the News

Global Financial Warriors

with John B. Taylor, George P. Shultzvia FrontPage Magazine
Wednesday, April 25, 2007

Frontpage Interview’s guest today is John B. Taylor, a senior fellow at the Hoover Institution and a professor of economics at Stanford...

In the News

Most Nations Fall Short of NAEP Proficiency, Analysis Finds

with Chester E. Finn Jr.via Education Week
Tuesday, April 24, 2007

Outside of a handful of Asian nations, the typical 8th grader in many foreign countries would not meet “proficient” levels on U.S. tests of mathematics and science, according to a reanalysis of international achievement data being published today...

In the News

Weighting for Lefty

with Diane Ravitchvia Village Voice
Tuesday, April 24, 2007

Math conferences aren't typically hotbeds of controversy...

In the News

Opinion Piece Discusses Provisions of Prescription Drug User Fee Act Legislation

with Richard A. Epsteinvia Kaisernetwork.org
Tuesday, April 24, 2007

egislation by Sen. Edward Kennedy (D-Mass.) that would reauthorize the Prescription Drug User Fee Act would raise fees to drug companies, but it "would be better if Congress ... increased its direct appropriation to an FDA that it saddles with ever more obligations," Richard Epstein, professor of law at the University of Chicago and a senior fellow at the Hoover Institution, writes in a Wall Street Journal opinion piece...

In the News

A Look Back at Yeltsin

with David Sattervia Power Line
Tuesday, April 24, 2007

Real Clear Politics offers two pieces about the legacy of Boris Yeltsin who died earlier this week...

In the News

The Loneliness of the Long-Distance Libertarian

with Milton Friedmanvia Reason
Tuesday, April 24, 2007

Libertarians have been delighted by some recent analysis via the Cato Institute’s David Boaz and the America’s Future Foundation’s David Kirby...